{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:32:43Z","timestamp":1792791163667,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jclinepi.2025.111711","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T11:25:10Z","timestamp":1738668310000},"page":"111711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Income inequality and access to advanced immunotherapy for lung cancer: the case of Durvalumab in the Netherlands"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-0206","authenticated-orcid":false,"given":"Dimitris","family":"Katsimpokis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke J.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs","family":"Geleijnse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jclinepi.2025.111711_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111711_bib2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.lungcan.2008.06.006","article-title":"Socioeconomic inequalities in lung cancer mortality in 16 European populations","volume":"63","author":"Van der Heyden","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jclinepi.2025.111711_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211011956","article-title":"Factors explaining socio-economic inequalities in cancer survival: a systematic review","volume":"28","author":"Afshar","year":"2021","journal-title":"Cancer Control"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111711_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/cancers14020398","article-title":"Socio-economic inequalities in lung cancer outcomes: an overview of systematic reviews","volume":"14","author":"Redondo-S\u00e1nchez","year":"2022","journal-title":"Cancers"},{"issue":"20","key":"10.1016\/j.jclinepi.2025.111711_bib5","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2025.111711_bib6","series-title":"Onderdeel van de initi\u00eble beoordeling van specialistische geneesmiddelen","year":"2019"},{"key":"10.1016\/j.jclinepi.2025.111711_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lungcan.2021.03.013","article-title":"Trends and variations in treatment of stage I\u2013III non-small cell lung cancer from 2008 to 2018: a nationwide population-based study from The Netherlands","volume":"155","author":"Evers","year":"2021","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111711_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/ije\/dyy167","article-title":"Differential vulnerability and susceptibility: how to make use of recent development in our understanding of mediation and interaction to tackle health inequalities","volume":"48","author":"Diderichsen","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111711_bib9","article-title":"Incidence and mortality of lung cancer: global trends and association with socioeconomic status","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jclinepi.2025.111711_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fonc.2018.00536","article-title":"Socioeconomic differences and lung cancer survival\u2014systematic review and meta-analysis","volume":"8","author":"Finke","year":"2018","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111711_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/0284186X.2014.1001037","article-title":"Socioeconomic position and survival after lung cancer: influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004\u20132010","volume":"54","author":"Dalton","year":"2015","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111711_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.32276","article-title":"Association of race, socioeconomic factors, and treatment characteristics with overall survival in patients with limited-stage small cell lung cancer","volume":"4","author":"Zhou","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111711_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.athoracsur.2019.07.017","article-title":"The effect of socioeconomic status on treatment and mortality in non-small cell lung cancer patients","volume":"109","author":"Ebner","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jclinepi.2025.111711_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v076.i01","article-title":"Stan: a probabilistic programming language","volume":"76","author":"Carpenter","year":"2017","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jclinepi.2025.111711_bib34","series-title":"Statistical Rethinking: A Bayesian Course with Examples in R and STAN","author":"McElreath","year":"2020"},{"key":"10.1016\/j.jclinepi.2025.111711_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2307\/271063","article-title":"Bayesian model selection in social research","volume":"25","author":"Raftery","year":"1995","journal-title":"Sociol Methodol"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111711_bib15","first-page":"2","article-title":"What are the odds? A practical guide to computing and reporting Bayes factors","volume":"7","author":"Jarosz","year":"2014","journal-title":"J Probl Solving"},{"issue":"6","key":"10.1016\/j.jclinepi.2025.111711_bib16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/EDE.0000000000000160","article-title":"The parametric g-formula for time-to-event data: intuition and a worked example","volume":"25","author":"Keil","year":"2014","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.jclinepi.2025.111711_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0894845317731157","article-title":"Career, family, and workforce mobility: an interdisciplinary conversation","volume":"47","author":"Patton","year":"2020","journal-title":"J Career Dev"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111711_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bimj.201900211","article-title":"Bayesian regularization for flexible baseline hazard functions in Cox survival models","volume":"63","author":"L\u00e1zaro","year":"2021","journal-title":"Biom J"},{"key":"10.1016\/j.jclinepi.2025.111711_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.jclinepi.2025.111711_bib20","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/annonc\/mdx204","article-title":"The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in The Netherlands","volume":"28","author":"Kuijer","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.jclinepi.2025.111711_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10549-021-06308-2","article-title":"The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in The Netherlands","volume":"189","author":"Filipe","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111711_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12904-020-0538-y","article-title":"Impact of socioeconomic status on end-of-life costs: a systematic review and meta-analysis","volume":"19","author":"Yu","year":"2020","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jclinepi.2025.111711_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.radonc.2022.10.028","article-title":"Trends and variation in the use of radiotherapy in non-metastatic prostate cancer: a 12-year nationwide overview from The Netherlands","volume":"177","author":"Evers","year":"2022","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111711_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clon.2024.01.013","article-title":"Trends and variation in the use of radiotherapy in non-metastatic rectal cancer: a 14-year nationwide overview from The Netherlands","volume":"36","author":"Verrijssen","year":"2024","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.jclinepi.2025.111711_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/heapro\/day062","article-title":"Does health literacy mediate the relationship between socioeconomic status and health disparities? Integrative review","volume":"34","author":"Stormacq","year":"2019","journal-title":"Health Promot Int"},{"issue":"sup2","key":"10.1016\/j.jclinepi.2025.111711_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/10810730.2016.1201175","article-title":"Health literacy mediates the relationship between educational attainment and health behavior: a Danish population-based study","volume":"21","author":"Friis","year":"2016","journal-title":"J Health Commun"},{"key":"10.1016\/j.jclinepi.2025.111711_bib27","series-title":"Gezondheidsvaardigheden in Nederland: factsheet cijfers 2021","author":"Willems","year":"2022"},{"issue":"22","key":"10.1016\/j.jclinepi.2025.111711_bib28","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1002\/cncr.33121","article-title":"Breast cancer treatment delays by socioeconomic and health care access latent classes in black and white women","volume":"126","author":"Emerson","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jclinepi.2025.111711_bib29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12885-017-3241-5","article-title":"Ethnic differences in colon cancer care in The Netherlands: a nationwide registry-based study","volume":"17","author":"Lamkaddem","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jclinepi.2025.111711_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/eurpub\/ckz012","article-title":"Do ethnic inequalities in multimorbidity reflect ethnic differences in socioeconomic status? The HELIUS study","volume":"29","author":"Verest","year":"2019","journal-title":"Eur J Public Health"},{"issue":"9836","key":"10.1016\/j.jclinepi.2025.111711_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jclinepi.2025.111711_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15245","article-title":"Epidemiologic characteristics of multimorbidity and sociodemographic factors associated with multimorbidity in a rapidly aging asian country","volume":"2","author":"Low","year":"2019","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435625000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T20:19:39Z","timestamp":1753388379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435625000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"alternative-id":["S0895435625000447"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111711","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.24.24306222","asserted-by":"object"}]},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Income inequality and access to advanced immunotherapy for lung cancer: the case of Durvalumab in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111711"}}